National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine
A cell-based cancer vaccine composed of autologous dendritic cells (DCs) pulsed with synthetic brain tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL)l and antibody responses against glioma tumor cells, resulting in glioma tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:Symadine, Symbicort, Symmetrel, Synestrin, Synovir
Next:synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine, synthetic human corticotropin-releasing factor, synthetic human papillomavirus 16 E6 peptide, synthetic melanoma-associated antigens vaccine, synthetic peptide-based erythropoiesis stimulating agent

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov